National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 74740-74741 [2020-25802]

Download as PDF 74740 Federal Register / Vol. 85, No. 226 / Monday, November 23, 2020 / Notices as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; DEACompliant Drug Detection and Deactivation Technology to Deter Opioid Theft in Hospitals for Next Generation Controlled Substance Diversion Prevention Program (CSDPP) Date: December 15, 2020. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 594–9460, Soyoun.cho@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: November 17, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–25800 Filed 11–20–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which VerDate Sep<11>2014 17:07 Nov 20, 2020 Jkt 253001 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Preclinical and Translational Vaccine Development Support for HIV and Other Candidate Agents (PTVDS) (N01), Task Areas C and D. Date: December 17, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Rockville, MD 20892 (Virtual Meeting). Contact Person: Cynthia L. De La Fuente, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Rockville, MD 20852, 240–669–2740, delafuentecl@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 17, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–25798 Filed 11–20–20; 8:45 am] Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Rockville, MD 20892 (Virtual Meeting). Contact Person: Cynthia L. De La Fuente, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Rockville, MD 20852, 240–669–2740, delafuentecl@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 17, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–25799 Filed 11–20–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Preclinical and Translational Vaccine Development Support for HIV and Other Candidate Agents (PTVDS), Task Areas A and B. Date: December 14, 2020. Time: 10:00 a.m. to 6:00 p.m. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). Date: December 16, 2020. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G60, Rockville, MD 20892 (Virtual Meeting). Contact Person: Gregory P. Jarosik, Ph.D. Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G60, Rockville, MD 20852, (240) 669–5080, gjarosik@niaid.nih.gov. E:\FR\FM\23NON1.SGM 23NON1 74741 Federal Register / Vol. 85, No. 226 / Monday, November 23, 2020 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 17, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–25802 Filed 11–20–20; 8:45 am] BILLING CODE 4140–01–P Background and Purpose DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2010–1066] Recreational Boating Safety Projects, Programs, and Activities Funded Under Provisions of the Fixing America’s Surface Transportation Act; Fiscal Year 2020 ACTION: published annually in the Federal Register. This notice specifies the funding amounts the Coast Guard has committed, obligated, or expended during fiscal year 2020, as of September 30, 2020. FOR FURTHER INFORMATION CONTACT: For questions on this notice please contact Mr. Jeff Decker, U.S. Coast Guard, Regulations Development Manager, (202) 372–1507 or: RBSInfo@uscg.mil. SUPPLEMENTARY INFORMATION: Notice. The Coast Guard is publishing this notice to satisfy a requirement of the Fixing America’s Surface Transportation Act that requires a detailed accounting of the projects, programs, and activities funded under the national recreational boating safety program provision of the Act be SUMMARY: Since 1998, Congress has passed a series of laws providing funding for projects, programs, and activities funded under the national recreational boating safety program, which is administered by the U.S. Coast Guard. For a detailed description of the legislative history, please see the Recreational Boating Safety Projects, Programs, and Activities Funded Under Provisions of the Fixing America’s Surface Transportation Act; Fiscal Year 2016 Notice published in the Federal Register on April 12, 2017 (82 FR 17671). These funds are available to the Secretary from the Sport Fish Restoration and Boating Trust Fund (Trust Fund) established under 26 U.S.C. 9504(a) for payment of Coast Guard expenses for personnel and activities directly related to coordinating and carrying out the national recreational boating safety program. Amounts made available under this subsection remain available during the two succeeding fiscal years. Any amount that is unexpended or unobligated at the end of the 3-year period during which it is available shall be withdrawn by the Secretary and allocated to the States in addition to any other amounts available for allocation in the fiscal year in which they are withdrawn or the following fiscal year. Use of these funds requires compliance with standard Federal contracting rules with associated lead and processing times resulting in a lag time between available funds and spending. The total amount of funding transferred to the Coast Guard from the Trust Fund, and committed, obligated, and/or expended during fiscal year 2020 for each project is shown below. Specific Accounting of Funds The total amount of funding transferred to the Coast Guard from the Sport Fish Restoration and Boating Trust Fund and committed, obligated, and/or expended during fiscal year 2020 for each project is shown in the chart below. Project Description 46 USC 43 Compliance: Inspection Program/Boat Testing Program. 46 USC 43 Compliance: Staff Salaries and Travel. Administrative Overhead .......................... Boating Accident Report Database (BARD) Web System. Provided for continuance of the national recreational boat compliance inspection program, which began in January 2001. Provided for personnel to oversee manufacturer compliance with 46 U.S.C. 43 requirements. Supplies and Materials to support the RBS Program ................................................. Provided for maintaining the BARD Web System, which enables reporting authorities in the 50 States, five U.S. Territories, and the District of Columbia to submit their accident reports electronically over a secure Internet connection. Provided contract personnel to conduct boating safety-related research and analysis. Provided to facilitate staff training on new grant management requirements ............. Provided for travel by employees of the Boating Safety Division to gather background and planning information for new recreational boating safety initiatives. Provided for 18 personnel directly related to coordinating and carrying out the national recreational boating safety program and Administrative Reserve Support. Provided for collecting data to support the National Recreational Boating Survey .... Contract Personnel Support ..................... Grant Management Training ..................... Recreational Boating Safety Program Travel. Reimbursable Salaries .............................. Survey ....................................................... Of the $8.307 million made available to the Coast Guard in fiscal year 2020, $709,802 has been committed, obligated, or expended and an additional $6,289,226 of prior fiscal year funds have been committed, obligated, or expended, as of September 30, 2020. The remainder of the FY19 and FY20 funds made available to the Coast Guard (approximately $9.231 million) may be retained for the allowable period for the National Recreational Boating Survey, the expected reengineering of the Boating Accident and Reporting VerDate Sep<11>2014 17:07 Nov 20, 2020 Jkt 253001 Database, and other projects, or it may be transferred into the pool of money available for allocation through the state grant program. Authority This notice is issued pursuant to 5 U.S.C. 552 and 46 U.S.C. 13107(c)(4). Dated: November 17, 2020. Wayne R. Arguin, Jr., Captain, U.S. Coast Guard, Director of Inspections and Compliance. [FR Doc. 2020–25775 Filed 11–20–20; 8:45 am] BILLING CODE 9110–04–P PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 Cost $2,041,346 560,150 37,506 514,186 924,254 96,501 41,433 2,733,653 50,000 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0048] Agency Information Collection Activities: Declaration of Person Who Performed Repairs or Alterations U.S. Customs and Border Protection (CBP), Department of Homeland Security. AGENCY: E:\FR\FM\23NON1.SGM 23NON1

Agencies

[Federal Register Volume 85, Number 226 (Monday, November 23, 2020)]
[Notices]
[Pages 74740-74741]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25802]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Investigator Initiated Program 
Project Applications (P01 Clinical Trial Not Allowed).
    Date: December 16, 2020.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G60, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Gregory P. Jarosik, Ph.D. Scientific Review 
Program, Division of Extramural Activities, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G60, Rockville, MD 20852, (240) 669-5080, 
[email protected].


[[Page 74741]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-25802 Filed 11-20-20; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.